JP Morgan Chase’s Axcella Health Inc. Common Stock AXLA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-1,073
| Closed | -$11.2K | – | 8098 |
|
|
2023
Q3 | $11.2K | Buy |
+1,073
| New | +$8.44K | ﹤0.01% | 6223 |
|
|
2023
Q2 | – | Sell |
-220
| Closed | -$2.06K | – | 6858 |
|
|
2023
Q1 | $3K | Buy |
220
+210
| +2,100% | +$2.8K | ﹤0.01% | 6377 |
|
|
2022
Q4 | $0 | Buy |
10
+2
| +25% | +$52 | ﹤0.01% | 7196 |
|
|
2022
Q3 | $0 | Hold |
8
| – | – | ﹤0.01% | 7021 |
|
|
2022
Q2 | $0 | Hold |
8
| – | – | ﹤0.01% | 7059 |
|
|
2022
Q1 | $1K | Hold |
8
| – | – | ﹤0.01% | 6513 |
|
|
2021
Q4 | $0 | Hold |
8
| – | – | ﹤0.01% | 7099 |
|
|
2021
Q3 | $1K | Sell |
8
-55
| -87% | -$4.71K | ﹤0.01% | 6423 |
|
|
2021
Q2 | $7K | Sell |
63
-1,137
| -95% | -$113K | ﹤0.01% | 6086 |
|
|
2021
Q1 | $143K | Buy |
1,200
+908
| +311% | +$128K | ﹤0.01% | 5282 |
|
|
2020
Q4 | $37K | Sell |
292
-264
| -47% | -$33.9K | ﹤0.01% | 5216 |
|
|
2020
Q3 | $65K | Buy |
556
+256
| +85% | +$31.5K | ﹤0.01% | 4865 |
|
|
2020
Q2 | $41K | Sell |
300
-1,022
| -77% | -$125K | ﹤0.01% | 4892 |
|
|
2020
Q1 | $113K | Buy |
1,322
+69
| +6% | +$7.07K | ﹤0.01% | 4482 |
|
|
2019
Q4 | $126K | Buy |
1,253
+1,232
| +5,867% | +$135K | ﹤0.01% | 4824 |
|
|
2019
Q3 | $3K | Buy |
21
+3
| +17% | +$556 | ﹤0.01% | 5616 |
|
|
2019
Q2 | $4K | Buy |
+18
| New | +$5.7K | ﹤0.01% | 5658 |
|
Other funds holding AXLA
JP Morgan Chase's AXLA Position: Q4 2023 in Review
JP Morgan Chase sold out of Axcella Health Inc. Common Stock (AXLA) in Q4 2023, closing a stake of 1,073 shares — an estimated $11.2K sold.
JP Morgan Chase first reported a position in AXLA in Q2 2019 and held it in 17 quarters. The position peaked at $143K in Q1 2021. 1 fund tracked by Wall St. Rank holds AXLA as of Q4 2023.
- JP Morgan Chase reported no remaining Axcella Health Inc. Common Stock position as of Q4 2023 after selling out during the quarter.
- JP Morgan Chase sold 1,073 Axcella Health Inc. Common Stock shares in Q4 2023, an estimated $11.2K.
- JP Morgan Chase first reported a position in Axcella Health Inc. Common Stock in Q2 2019 and held it in 17 quarters.
- JP Morgan Chase's Axcella Health Inc. Common Stock position peaked at $143K in Q1 2021.
- 1 fund tracked by Wall St. Rank held Axcella Health Inc. Common Stock as of Q4 2023.
Based on JP Morgan Chase's 13F filing for Q4 2023, filed 12 Feb 2024.